• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Seattle Genetics

Seattle Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Increasing Demand in ADCs to Create Opportunities for the Global Monoclonal Antibodies Market until 2020, Reports Technavio

    Increasing Demand in ADCs to Create Opportunities for the Global Monoclonal Antibodies Market until 2020, Reports Technavio

  2. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  3. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

  4. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  5. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.